urea and syringolin b

urea has been researched along with syringolin b in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachmann, AS; Clerc, J; Dudler, R; Groll, M; Huber, R; Illich, DJ; Kaiser, M; Schellenberg, B1
Biswas, G; Ibarra-Rivera, TR; Pirrung, MC1
Agarwal, P; Anshu, A; Ibarra-Rivera, TR; Pirrung, MC; Schönthal, AH; Thomas, S1
Kaiser, M; Krahn, D; Walsh, CT; Wuest, WM1
Kaiser, M; Krahn, D; Ottmann, C1
Bachmann, AS; Ibarra-Rivera, TR; Opoku-Ansah, J; Pirrung, MC1
Bian, X; Huang, F; Müller, R; Stewart, FA; Xia, L; Zhang, Y1

Reviews

1 review(s) available for urea and syringolin b

ArticleYear
The chemistry and biology of syringolins, glidobactins and cepafungins (syrbactins).
    Natural product reports, 2011, Volume: 28, Issue:11

    Topics: Biological Products; Humans; Molecular Structure; Peptides, Cyclic; Proteasome Inhibitors; Urea

2011

Other Studies

6 other study(ies) available for urea and syringolin b

ArticleYear
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Apr-21, Volume: 106, Issue:16

    Topics: Humans; Kinetics; Lipids; Peptides, Cyclic; Proteasome Inhibitors; Substrate Specificity; Urea; X-Rays

2009
Total synthesis of syringolin A and B.
    Organic letters, 2010, May-21, Volume: 12, Issue:10

    Topics: Molecular Conformation; Peptides, Cyclic; Protease Inhibitors; Proteasome Inhibitors; Stereoisomerism; Urea

2010
Novel proteasome-inhibitory syrbactin analogs inducing endoplasmic reticulum stress and apoptosis in hematological tumor cell lines.
    Biochemical pharmacology, 2011, Sep-15, Volume: 82, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Hematologic Neoplasms; Humans; Immunoblotting; Molecular Structure; Oxidative Stress; Peptides, Cyclic; Proteasome Inhibitors; Urea

2011
Enzymatic timing and tailoring of macrolactamization in syringolin biosynthesis.
    Organic letters, 2011, Sep-02, Volume: 13, Issue:17

    Topics: Molecular Structure; Peptides, Cyclic; Stereoisomerism; Thiolester Hydrolases; Urea

2011
Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
    Pharmaceutical biology, 2012, Volume: 50, Issue:1

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Multiple Myeloma; Neuroblastoma; Peptides, Cyclic; Proteasome Inhibitors; Pyrazines; Urea

2012
Direct cloning, genetic engineering, and heterologous expression of the syringolin biosynthetic gene cluster in E. coli through Red/ET recombineering.
    Chembiochem : a European journal of chemical biology, 2012, Sep-03, Volume: 13, Issue:13

    Topics: Biosynthetic Pathways; Cloning, Molecular; Escherichia coli; Genetic Engineering; Multigene Family; Peptides, Cyclic; Pseudomonas syringae; Urea

2012